Your browser is no longer supported. Please, upgrade your browser.
Settings
RPRX [NASD]
Royalty Pharma plc
Index- P/E- EPS (ttm)- Insider Own17.50% Shs Outstand370.00M Perf Week1.33%
Market Cap31.46B Forward P/E19.17 EPS next Y2.71 Insider Trans-6.83% Shs Float83.12M Perf Month18.47%
Income- PEG- EPS next Q0.75 Inst Own44.40% Short Float16.00% Perf Quarter22.29%
Sales2.01B P/S15.67 EPS this Y70.50% Inst Trans4.40% Short Ratio4.98 Perf Half Y17.56%
Book/sh12.03 P/B4.32 EPS next Y10.66% ROA- Target Price52.14 Perf Year-
Cash/sh4.51 P/C11.51 EPS next 5Y7.10% ROE- 52W Range34.80 - 56.50 Perf YTD3.80%
Dividend0.60 P/FCF- EPS past 5Y- ROI21.30% 52W High-8.05% Beta-
Dividend %1.15% Quick Ratio10.30 Sales past 5Y- Gross Margin- 52W Low49.28% ATR2.18
Employees35 Current Ratio10.30 Sales Q/Q17.70% Oper. Margin- RSI (14)65.20 Volatility4.33% 4.53%
OptionableYes Debt/Eq1.31 EPS Q/Q208.30% Profit Margin- Rel Volume1.62 Prev Close51.25
ShortableYes LT Debt/Eq1.31 EarningsNov 11 BMO Payout- Avg Volume2.67M Price51.95
Recom2.40 SMA207.30% SMA5017.05% SMA20019.17% Volume4,320,198 Change1.37%
Nov-09-20Upgrade UBS Neutral → Buy $52 → $51
Jul-14-20Initiated Evercore ISI In-line
Jul-13-20Initiated UBS Neutral $52
Jul-13-20Initiated SunTrust Buy $56
Jul-13-20Initiated Morgan Stanley Equal-Weight $51
Jul-13-20Initiated JP Morgan Neutral $50
Jul-13-20Initiated Goldman Neutral $47
Jul-13-20Initiated Cowen Outperform $55
Jul-13-20Initiated Citigroup Neutral $50
Jul-13-20Initiated BofA Securities Buy $55
Jan-08-21 08:05AM  
08:00AM  
Jan-07-21 04:15PM  
Dec-23-20 03:16PM  
Dec-22-20 08:30AM  
Dec-21-20 08:12AM  
Dec-17-20 04:29PM  
Dec-07-20 08:45AM  
08:40AM  
Dec-04-20 04:31PM  
Nov-16-20 03:39AM  
Nov-10-20 05:40PM  
Nov-02-20 07:30AM  
Oct-20-20 04:32PM  
Oct-19-20 09:00AM  
Oct-15-20 11:45PM  
09:15AM  
Oct-13-20 04:10PM  
Oct-02-20 07:00AM  
Sep-16-20 11:42AM  
Sep-02-20 04:25PM  
08:00AM  
Aug-25-20 08:14AM  
08:00AM  
Aug-19-20 09:00AM  
Aug-12-20 07:00AM  
Aug-07-20 09:40AM  
Aug-03-20 04:15PM  
Jul-20-20 04:15PM  
07:45AM  
Jul-17-20 12:00PM  
Jul-15-20 04:33PM  
Jul-13-20 10:16AM  
Jul-02-20 01:02PM  
Jul-01-20 01:48PM  
Jun-30-20 10:40AM  
Jun-27-20 07:13PM  
Jun-26-20 04:42PM  
Jun-25-20 07:01PM  
08:43AM  
Jun-22-20 06:10PM  
Jun-18-20 04:15PM  
12:37PM  
09:53AM  
Jun-17-20 09:55AM  
06:06AM  
Jun-16-20 06:21PM  
05:34PM  
04:21PM  
03:21PM  
12:14PM  
12:10PM  
09:32AM  
07:07AM  
Jun-15-20 11:29PM  
07:21PM  
Royalty Pharma plc operates in the biopharmaceutical industry. The company operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry. It is involved in the identification, evaluation, and acquisition of royalties and royalty-related assets on various biopharmaceutical therapies. The company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. Its portfolio includes royalties on approximately 45 commercial products and three development-stage product candidates. The company has royalties on various therapeutic areas and drug classes, including Neulasta, Neupogen, Rituxan, Imbruvica, Trodelvy, Tazverik, and Xtandi in oncology; Lyrica in neuropathic pain; Biktarvy, Genvoya, Prezista, Symtuza, Truvada, and Atripla in HIV; Humira, Remicade, and Cimzia TNF inhibitors; Kalydeco, Orkambi, Symdeko, and Trikafta in cystic fibrosis; Tecfidera and Tysabri in multiple sclerosis; Emgality, Nurtec ODT (rimegepant), and vazegepant in migraine; and others. Royalty Pharma plc was founded in 1996 and is based in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ADAGE CAPITAL PARTNERS GP, L.L10% OwnerDec 18Sale44.02101,0504,448,22138,714,280Dec 18 02:36 PM
ADAGE CAPITAL PARTNERS GP, L.L10% OwnerDec 17Sale43.927,200,000316,224,00038,815,330Dec 18 02:36 PM
RIGGS RORY BDirectorOct 20Sale42.00463,20019,454,4000Oct 22 09:48 PM
Coyne Terrance P.EVP & CFOJun 18Buy28.001,45040,6001,450Jun 23 09:21 PM
Coyne Terrance P.EVP & CFOJun 18Buy28.001,50042,0001,500Jun 23 09:21 PM
RIGGS RORY BDirectorJun 18Buy28.0015,000420,00015,000Jun 23 09:14 PM
Hite ChristopherEVP & Vice ChairmanJun 18Buy28.0070,0001,960,00070,000Jun 23 09:13 PM
FORD WILLIAM EDirectorJun 18Buy28.001,500,00042,000,0001,500,000Jun 22 09:55 PM
Legorreta Pablo G.CEO, Chairman of the BoardJun 18Buy28.0020,000560,00010,000Jun 22 09:55 PM
Lloyd George W.EVP, Investments & GCJun 18Buy28.0011,200313,60011,200Jun 22 09:54 PM
Lloyd George W.EVP, Investments & GCJun 18Buy28.003,00084,0003,000Jun 22 09:54 PM
Giuliani Mario GermanoDirectorJun 18Buy28.0050,0001,400,00050,000Jun 22 09:47 PM
ADAGE CAPITAL PARTNERS GP, L.L10% OwnerJun 18Buy28.003,000,00084,000,00046,015,330Jun 22 05:31 PM